Gene · 8202
Papers3,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer. | Cancers (Basel) | 2021 | 34680281 | PubTator, text mining | PubMed |
| Proteome-wide profiling of transcriptional machinery on accessible chromatin with biotinylated transposons. | Sci Adv | 2021 | 34678055 | PubTator, text mining | PubMed |
| Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment. | Int J Biol Sci | 2021 | 34671213 | PubTator, text mining | PubMed |
| Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. | Mol Neurodegener | 2021 | 34663413 | PubTator, text mining | PubMed |
| Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment. | J Cell Mol Med | 2021 | 34651424 | PubTator, text mining | PubMed |
| Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer. | Int J Mol Sci | 2021 | 34638949 | PubTator, text mining | PubMed |
| Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules. | Int J Mol Sci | 2021 | 34638867 | PubTator, text mining | PubMed |
| Molecular Stratification of Childhood Ependymomas as a Basis for Personalized Diagnostics and Treatment. | Cancers (Basel) | 2021 | 34638438 | PubTator, text mining | PubMed |
| Steroid Receptors in Breast Cancer: Understanding of Molecular Function as a Basis for Effective Therapy Development. | Cancers (Basel) | 2021 | 34638264 | PubTator, text mining | PubMed |
| Inhibition of GATA2 in prostate cancer by a clinically available small molecule. | Endocr Relat Cancer | 2021 | 34636746 | PubTator, text mining | PubMed |
| Molecular Basis of Prostate Cancer and Natural Products as Potential Chemotherapeutic and Chemopreventive Agents. | Front Pharmacol | 2021 | 34630112 | PubTator, text mining | PubMed |
| Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies. | J Mol Med (Berl) | 2021 | 34623477 | PubTator, text mining | PubMed |
| Relieving Cellular Energy Stress in Aging, Neurodegenerative, and Metabolic Diseases, SIRT1 as a Therapeutic and Promising Node. | Front Aging Neurosci | 2021 | 34616289 | PubTator, text mining | PubMed |
| Calmodulin acetylation: A modification to remember. | J Biol Chem | 2021 | 34606826 | PubTator, text mining | PubMed |
| SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition. | Nat Commun | 2021 | 34599168 | PubTator, text mining | PubMed |
| PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance. | J Exp Clin Cancer Res | 2021 | 34593007 | PubTator, text mining | PubMed |
| SPOP mutation induces DNA methylation via stabilizing GLP/G9a. | Nat Commun | 2021 | 34588438 | PubTator, text mining | PubMed |
| Inhibition of nuclear receptor RORα attenuates cartilage damage in osteoarthritis by modulating IL-6/STAT3 pathway. | Cell Death Dis | 2021 | 34584074 | PubTator, text mining | PubMed |
| The Evolving Role of Ferroptosis in Breast Cancer: Translational Implications Present and Future. | Cancers (Basel) | 2021 | 34572802 | PubTator, text mining | PubMed |
| Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics. | Biomolecules | 2021 | 34572488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8202/papers?page=35